Vaccine stability study design and analysis to support product licensure.
Stability evaluation supporting vaccine licensure includes studies of bulk intermediates as well as final container product. Long-term and accelerated studies are performed to support shelf life and to determine release limits for the vaccine. Vaccine shelf life is best determined utilizing a formal statistical evaluation outlined in the ICH guidelines, while minimum release is calculated to help assure adequate potency through handling and storage of the vaccine. In addition to supporting release potency determination, accelerated stability studies may be used to support a strategy to recalculate product expiry after an unintended temperature excursion such as a cold storage unit failure or mishandling during transport. Appropriate statistical evaluation of vaccine stability data promotes strategic stability study design, in order to reduce the uncertainty associated with the determination of the degradation rate, and the associated risk to the customer.
Schofield
Timothy L
TL
Merck Research Laboratories, West Point, PA, USA. timothy.schofield@gsk.com
D002626:Chemistry, Pharmaceutical / Q000331:legislation & jurisprudence* / Q000379:methods; D003627:Data Interpretation, Statistical; D004341:Drug Evaluation / Q000331:legislation & jurisprudence / Q000379:methods* / Q000706:statistics & numerical data; D004355:Drug Stability; D006801:Humans; D008009:Licensure, Pharmacy; D008458:Measles Vaccine / Q000493:pharmacokinetics; D012107:Research Design; D013997:Time Factors; D014612:Vaccines / Q000493:pharmacokinetics*
D008458:Measles Vaccine; D014612:Vaccines